Abstract:Background Hepatic caveolin-1 (CAV1) is reduced in cholesterol gallstone disease (CGD). Mice with CAV1 deficiency were prone to develop CGD. However, it remains unknown whether restored hepatic CAV1 expression prevents the development of CGD. Methods C57BL/6 mice were injected with adeno-associated virus 2/8 (AAV2/8) vectors carrying the CAV1 gene ((AAV2/8)CAV1) via intravenous (i.v.) or intraperitoneal (i.p.) route and then subjected to a lithogenic diet (LD) for 8 weeks. Uninjected mice were used as controls. The functional consequences of rescuing CAV1 expression by either i.v. or i.p. (AAV2/8)CAV1 treatment for CGD prevention and its subsequent molecular mechanisms were examined. Results CAV1 expression was reduced in the liver and gallbladder of LD-fed CGD mice. We discovered that (AAV2/8)CAV1 i.p. delivery results in higher transduction efficiency in the gallbladder than tail vein administration. Although either i.v. or i.p. injection of (AAV2/8)CAV1 improved liver lipid metabolic abnormalities in CGD mice but did not affect LD feeding-induced bile cholesterol supersaturation. In comparison with i.v. administration route, i.p. administration of (AAV2/8)CAV1 obviously increased CAV1 protein levels in the gallbladder of LD-fed mice, and i.p. delivery of (AAV2/8)CAV1 partially improved gallbladder cholecystokinin receptor (CCKAR) responsiveness and impeded bile cholesterol nucleation via the activation of adenosine monophosphate-activated protein kinase (AMPK) signaling, which induced a reduction in gallbladder mucin-1 (MUC1) and MUC5ac expression and gallbladder cholesterol accumulation. Conclusion CGD prevention by i.p. (AAV2/8)CAV1 injection in LD-fed mice was associated with the improvement of gallbladder stasis, which again supported the notion that supersaturated bile is required but not sufficient for the formation of cholesterol gallstones. Additionally, AAV treatment via the local i.p. injection offers particular advantages over the systemic i.v. route for much more effective gallbladder gene delivery, which will be an excellent tool for conducting preclinical functional studies on the maintenance of normal gallbladder function to prevent CGD.

Expression and Its Significance of Caveolin–1 in Liver and Gallbladder of Gallstone Mice Model

Adeno-associated Virus-Based Caveolin-1 Delivery Via Different Routes for the Prevention of Cholesterol Gallstone Formation

Differences Between Hepatic and Biliary Lipid Metabolism and Secretion in Genetically Gallstone-Susceptible and Gallstone-Resistant Mice

Association of Caveolin-3 and Cholecystokinin A Receptor with Cholesterol Gallstone Disease in Mice

Characteristics of Mrna Levels of Hepatic Cholesterol Metabolism Regulatory Enzymes in Genetically Gallstone-Susceptible and Resistant Mice

Studies on the Role of Caveolin-1 in Non-Alcoholic Steatohepatitis

Effect of Hepatic NPC1L1 on Cholesterol Gallstone Disease and Its Mechanism

Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.

Characteristics of Mrna Levels of Hepatic Key Enzymes in Cholesterol Metabolism of Genetically Gallstone-Susceptible Mice.

Upregulation of Caveolin-1 and SR-B1 in Mice with Non-Alcoholic Fatty Liver Disease

Mrna of SCP2 and Cholesterol Saturation Index Are Increased During Gallstone Formation in C57BL/6 Mice

Caveolin1 Protects Against Diet Induced Hepatic Lipid Accumulation in Mice.

Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice

CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts

Changes of Caveolin-1 in the Livers of Mice with Nonalcoholic Fatty Liver Disease Caused by Highfat Diet

Liver metabolism and cholesterol gallstone formation in SRA knockout mice with lithogenic diet

The mRNA expression of hepatic scavenger receptor B type I and liver receptor homologue 1 in Patients with cholesterol gallstone disease

Alteration of Gut Microbiota in Association with Cholesterol Gallstone Formation in Mice

Cav‐1 regulates the bile salt export pump on the canalicular membrane of hepatocytes by PKCα‐associated signalling under cholesterol stimulation

The expression of ransient receptor potential canonical 1 in the smooth muscle of guinea pig gallbladder and its role in stone formation

The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models